Gout can be successfully managed in these people with consideration of the influence of medications used for gout and their impact on the components of the metabolic syndrome and on chronic renal ...
The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...